Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Oct;18(4):583-607.
doi: 10.1128/CMR.18.4.583-607.2005.

Current and developing technologies for monitoring agents of bioterrorism and biowarfare

Affiliations
Review

Current and developing technologies for monitoring agents of bioterrorism and biowarfare

Daniel V Lim et al. Clin Microbiol Rev. 2005 Oct.

Abstract

Recent events have made public health officials acutely aware of the importance of rapidly and accurately detecting acts of bioterrorism. Because bioterrorism is difficult to predict or prevent, reliable platforms to rapidly detect and identify biothreat agents are important to minimize the spread of these agents and to protect the public health. These platforms must not only be sensitive and specific, but must also be able to accurately detect a variety of pathogens, including modified or previously uncharacterized agents, directly from complex sample matrices. Various commercial tests utilizing biochemical, immunological, nucleic acid, and bioluminescence procedures are currently available to identify biological threat agents. Newer tests have also been developed to identify such agents using aptamers, biochips, evanescent wave biosensors, cantilevers, living cells, and other innovative technologies. This review describes these current and developing technologies and considers challenges to rapid, accurate detection of biothreat agents. Although there is no ideal platform, many of these technologies have proved invaluable for the detection and identification of biothreat agents.

PubMed Disclaimer

References

    1. Aathithan, S., J. C. Plant, A. N. Chaudry, and G. L. French. 2001. Diagnosis of bacteria by detection of volatile organic compounds in urine using an automated headspace analyzer with multiple conducting polymer sensors. J. Clin. Microbiol. 39:2590-2593. - PMC - PubMed
    1. Aberl, F., and C. Kösslinger. 1998. Biosensor-based methods in clinical diagnosis. In Molecular diagnosis of infectious diseases, vol. 13. Humana Press, Inc., Totowa, N.J. - PubMed
    1. Abu Al-Soud, W., and P. Radstrom. 1998. Capacity of nine thermostable DNA polymerases to mediate DNA amplification in the presence of PCR-inhibiting samples. Appl. Environ. Microbiol. 64:3748-3753. - PMC - PubMed
    1. Akane, A., K. Matsubara, H. Nakamura, S. Takahashi, and K. Kimura. 1994. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J. Forensic Sci. 39:362-372. - PubMed
    1. Alexander, T. A., P. M. Pellegrino, and J. B. Gillespie. 2003. Near-infrared surface-enhanced-Raman-scattering-mediated detection of single optically trapped bacterial spores. Appl. Spectrosc. 57:1340-1345. - PubMed

MeSH terms